Related Experiment Video
Updated: Jul 7, 2026

Implantation of the Syncardia Total Artificial Heart
Published on: July 18, 2014
Retrograde hot-shot cardioplegia in patients with left ventricular hypertrophy undergoing aortic valve replacement
Raimondo Ascione1, Saadeh M Suleiman, Gianni D Angelini
1Bristol Heart Institute, University of Bristol, Bristol, United Kingdom. r.ascionen@bristol.ac.uk
Insights
Adding a warm-blood hot-shot reperfusion to cold-blood cardioplegia did not improve myocardial protection in patients undergoing aortic valve replacement. The technique showed a potential benefit for reducing ischemic stress in the right ventricle.
Area of Science:
- Cardiology
- Cardiac Surgery
- Cardioplegia
Background:
- Cold-blood cardioplegia with warm-blood hot-shot reperfusion may reduce myocardial injury during coronary surgery.
- Its effectiveness in patients with left ventricular hypertrophy due to aortic stenosis is not well-established.
Purpose of the Study:
- To evaluate the efficacy of adding a retrograde warm-blood hot-shot to antegrade cold-blood cardioplegia in preventing myocardial injury.
- To assess myocardial protection in patients with left ventricular hypertrophy undergoing aortic valve replacement.
Main Methods:
- Prospective randomized trial of 36 patients undergoing aortic valve replacement.
- Comparison of cold-blood cardioplegia alone versus cold-blood cardioplegia with retrograde hot-shot.
- Assessment of myocardial adenosine triphosphate and lactate levels, and troponin I release.
Main Results:
- No significant difference in myocardial adenosine triphosphate or lactate levels post-reperfusion between groups.
- A trend towards decreased adenosine triphosphate in the cold-blood cardioplegia group, significant in the right ventricle.
- Elevated troponin I in both groups, not indicative of myocardial infarction.
Conclusions:
- Terminal retrograde hot-shot reperfusion offers no additional benefit over antegrade cold-blood cardioplegia for myocardial protection in this patient group.
- A potential benefit for reducing right ventricular ischemic stress was observed.
- No significant difference in clinical outcomes was noted between the two groups.
Background:
Intermittent antegrade cold-blood cardioplegia followed by terminal warm-blood cardioplegic reperfusion or hot-shot is reported to reduce myocardial injury in the setting of coronary surgery. The efficacy of this cardioplegic technique in patients with left ventricular hypertrophy secondary to aortic stenosis remains uncertain.
Methods:
Thirty-six patients with left ventricular hypertrophy undergoing aortic valve replacement were prospectively randomized to cold-blood cardioplegia either alone (cold-blood cardioplegia group) or with retrograde hot-shot (hot-shot group). Reperfusion injury was assessed by measuring myocardial levels of adenosine triphosphate and lactate in left and right ventricular biopsies taken 5 minutes after institution of cardiopulmonary bypass and 20 minutes after removal of cross-clamp using high-performance liquid chromatography and enzymatic techniques. Myocardial injury was assessed by serial release of troponin I up to 48 hours postoperatively. Overall clinical outcome was prospectively collected.
Results:
Baseline and intraoperative characteristics were similar between groups. In the hot-shot group, there were no significant changes in the myocardial concentration of adenosine triphosphate and lactate in both left and right ventricular biopsies after reperfusion. In the cold-blood cardioplegia group, there was a trend to a fall in adenosine triphosphate levels in the left and right ventricular biopsies after reperfusion, but this reached statistical significance only in the right ventricle. Troponin I release was raised in both groups at 4 and 12 hours after surgery (p < 0.05), but did not reach levels of myocardial infarction.
Conclusions:
The terminal retrograde hot-shot reperfusion does not add any extra benefit to antegrade cold-blood cardioplegia in preventing myocardial injury in patients with left ventricular hypertrophy undergoing aortic valve replacement. Nevertheless, it appears to reduce ischemic stress in the right ventricle. There was no difference in clinical outcome between groups.
Related Concept Videos
Cardiomyopathy III: Hypertrophic Cardiomyopathy
Aortic Regurgitation III: Medical Management
Cardiomyopathy V: Interprofessional Care
Aortic Regurgitation I: Introduction
Cardiomyopathy VII: Pre and Post Operative Nursing Management
Cardiac Catheterization III: Left Heart Catheterization

